03/21/2019
4:01 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities |  |
03/21/2019
8:02 AM | Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2019
6:50 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
3:57 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
3:57 PM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2019
3:50 PM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2019
3:45 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
4:22 PM | Esperion Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
| Form SC 13G/A
| |
02/14/2019
3:30 PM | Esperion Therapeutics (Subject)
Pentwater Capital Management LP (Filed by)
| Form SC 13G/A
| |
02/14/2019
10:16 AM | Esperion Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/11/2019
1:17 PM | Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G
| |
01/07/2019
4:10 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
6:45 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2019
9:57 AM | Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
| Form SC 13G/A
| |
12/26/2018
10:44 AM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
4:07 PM | Esperion Therapeutics (Issuer)
Glickman Mark A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/21/2018
4:03 PM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/21/2018
4:03 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2018
12:14 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:18 PM | Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:17 PM | Esperion Therapeutics (Issuer)
Lalwani Narendra D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
4:15 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2018
6:56 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Esperion Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2018
4:00 PM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2018
3:20 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2018
3:35 PM | Boxer Capital, LLC (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A
| |
10/30/2018
3:33 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Braslyn Ltd. (Reporting)
Esperion Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
Tuesday Thirteen Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/29/2018
6:45 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2018
4:05 PM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2018
3:56 PM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2018
6:15 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2018
6:18 AM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2018
2:23 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2018
3:31 PM | Esperion Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2018
6:31 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2018
10:55 AM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2018
4:06 PM | Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2018
11:43 AM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2018
1:59 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2018
4:08 PM | Esperion Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2018
1:34 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2018
3:34 PM | Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2018
3:34 PM | Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2018
3:32 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2018
3:18 PM | Braunstein Scott (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2018
3:18 PM | Esperion Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2018
3:17 PM | Esperion Therapeutics (Issuer)
GOTTO ANTONIO M JR MD D PHIL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2018
3:17 PM | Esperion Therapeutics (Issuer)
JANNEY DANIEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2018
3:17 PM | Esperion Therapeutics (Issuer)
MCGOVERN MARK E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2018
3:16 PM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2018
3:15 PM | Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2018
3:11 PM | Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2018
7:25 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2018
2:49 PM | BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2018
3:06 PM | Esperion Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
| Form SC 13G
| |
05/11/2018
3:16 PM | Boxer Capital, LLC (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G
| |
05/10/2018
3:22 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A
| |
05/08/2018
6:41 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2018
7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2018
6:55 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/13/2018
3:32 PM | Esperion Therapeutics (Filer)
| Form DEF 14A
| |
03/29/2018
6:47 PM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2018
6:46 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2018
7:00 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2018
3:38 PM | Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/20/2018
3:37 PM | Esperion Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/20/2018
3:33 PM | Esperion Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2018
7:06 AM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2018
4:27 PM | Esperion Therapeutics (Subject)
Pentwater Capital Management LP (Filed by)
| Form SC 13G/A
| |
02/14/2018
2:54 PM | BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A
| |
02/09/2018
4:47 PM | Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2018
4:29 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2018
1:42 PM | BlackRock Inc. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13G/A
| |
01/29/2018
12:25 PM | DOMAIN PARTERS VII L P (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13D/A
| |
01/26/2018
4:24 PM | Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2018
7:49 PM | Esperion Therapeutics (Issuer)
JANNEY DANIEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2018
8:28 AM | Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
| Form SC 13G/A
| |
01/03/2018
5:01 PM | Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2018
5:01 PM | Esperion Therapeutics (Issuer)
Lalwani Narendra D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2018
5:00 PM | Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2017
10:45 AM | Alta Partners VIII, L.P. (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13D/A
| |
12/20/2017
4:53 PM | Esperion Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2017
3:50 PM | Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/14/2017
3:48 PM | Esperion Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/08/2017
3:42 PM | Esperion Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2017
3:26 PM | DOMAIN PARTERS VII L P (Filed by)
Esperion Therapeutics (Subject)
| Form SC 13D/A
| |
12/08/2017
3:14 PM | Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
